These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 33066548

  • 1. Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
    Kitagawa K, Moriya K, Kaji K, Saikawa S, Sato S, Nishimura N, Namisaki T, Akahane T, Mitoro A, Yoshiji H.
    Int J Mol Sci; 2020 Oct 14; 21(20):. PubMed ID: 33066548
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cannabidiol exhibits potent anti-cancer activity against gemcitabine-resistant cholangiocarcinoma via ER-stress induction in vitro and in vivo.
    Pongking T, Thongpon P, Intuyod K, Klungsaeng S, Thanan R, Chaidee A, Charoenram N, Kongsintaweesuk S, Sakonsinsiri C, Vaeteewoottacharn K, Pinlaor S, Pinlaor P.
    BMC Complement Med Ther; 2024 Aug 30; 24(1):325. PubMed ID: 39215312
    [Abstract] [Full Text] [Related]

  • 8. Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo.
    Sungwan P, Kidoikhammouan S, Thonsri U, Saengboonmee C, Wongkham S, Okada S, Seubwai W.
    In Vivo; 2024 Aug 30; 38(5):2284-2293. PubMed ID: 39187317
    [Abstract] [Full Text] [Related]

  • 9. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.
    Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X.
    Int J Biol Sci; 2022 Aug 30; 18(1):43-64. PubMed ID: 34975317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
    Lu M, Qin X, Zhou Y, Li G, Liu Z, Geng X, Yue H.
    Cell Death Dis; 2021 Jan 12; 12(1):72. PubMed ID: 33436545
    [Abstract] [Full Text] [Related]

  • 13. Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
    Wang Y, Yu H, Xie X, Deng T, Ye L, Wu L, Ding X, Yang Z, Zhu Q, Li J, Zheng Y, Yu Z, Chen G.
    Oncogene; 2021 Jun 12; 40(25):4324-4337. PubMed ID: 34079085
    [Abstract] [Full Text] [Related]

  • 14. A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.
    Liang S, Guo H, Ma K, Li X, Wu D, Wang Y, Wang W, Zhang S, Cui Y, Liu Y, Sun L, Zhang B, Xin M, Zhang N, Zhou H, Liu Y, Wang J, Liu L.
    Cancer Res; 2021 Dec 01; 81(23):5889-5903. PubMed ID: 34580062
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma.
    Ito Y, Yamada D, Kobayashi S, Sasaki K, Iwagami Y, Tomimaru Y, Asaoka T, Noda T, Takahashi H, Shimizu J, Doki Y, Eguchi H.
    Cancer Lett; 2024 Jul 28; 595():216997. PubMed ID: 38801887
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma.
    Zhao X, Wen F, Wang W, Lu Z, Guo Q.
    Nutr Cancer; 2019 Jul 28; 71(2):246-256. PubMed ID: 30633583
    [Abstract] [Full Text] [Related]

  • 20. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD, Cadamuro M, Brivio S, Vismara M, Stecca T, Massani M, Bassi N, Furlanetto A, Joplin RE, Floreani A, Fabris L, Strazzabosco M.
    Oncotarget; 2015 Sep 22; 6(28):26052-64. PubMed ID: 26296968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.